SPARK Neuro SPARK Neuro is a neuroscience company that provides drug development and clinical care solutions. | ![]() SurModics SurModics is a provider of surface modification, drug delivery and in vitro diagnostic technologies to the healthcare industry. | ![]() SiteOne Therapeutics SiteOne Therapeutics is a company that develops therapeutics for the treatment of hypersensitivity disorders. | ![]() Inflazome Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome. | |
Founding Date | Founding Date 2016 | Founding Date 1979 | Founding Date 2014 | Founding Date 2016 |
Type | Type Private | Type Public | Type Private | Type Subsidiary |
Tags | ||||
Locations | Locations Santa Monica, US HQ | Locations Eden Prairie, US HQ Galway, IE Eden Prairie, US | Locations San Francisco, US HQ Bozeman, US | Locations Dublin 2, IE HQ Brisbane City, AU Cambridge, GB |
Employees | Employees 234% decrease | Employees 3699% increase | Employees 2216% increase | Employees 156% decrease |
Valuation ($) | Valuation ($) 53.5 m | Valuation ($) 539.3 m | Valuation ($) 75 m | Valuation ($) N/A |
Funding | ||||
Latest funding round | Latest funding round $ 13.5m (almost 8 years ago) | Latest funding round N/A | Latest funding round $ 15m (over 9 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 13.5m | Total funding raised N/A | Total funding raised $ 17.8m | Total funding raised $ 17m |

SurModics is a provider of surface modification, drug delivery and in vitro diagnostic technologies to the healthcare industry.
View company
SiteOne Therapeutics is a company that develops therapeutics for the treatment of hypersensitivity disorders.
View company
Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome.
View company